Hallucinogen Use and Mania Risk: What You Need to Know | Study Explained (2025)

Imagine this: You're experimenting with mind-altering substances like LSD, psilocybin, or ketamine, thinking it's just a wild trip or maybe even a therapeutic breakthrough for your mental health struggles. But what if that one intense experience lands you in the emergency room—and then, years later, sets off a rollercoaster of manic episodes or bipolar disorder? It's a chilling thought that could change how we view these so-called 'psychedelic' drugs forever. Dive in as we unpack a groundbreaking study that reveals a startling link, and get ready for some eye-opening insights that might just make you question everything you've heard about hallucinogens.

In a world where hallucinogens are gaining popularity—not just for recreational highs but increasingly in clinical settings to tackle tough conditions like depression and PTSD—new research is shining a light on potential dangers. A study published on December 2nd in the open-access journal PLOS Medicine, led by Daniel Myran from North York General Hospital in Canada, along with his team, has uncovered a concerning pattern. People who end up in emergency rooms or hospitals because of hallucinogen use face a dramatically higher chance of needing care for mania in the following three years. Mania, for those new to this, is a period of intense euphoria, racing thoughts, hyperactivity, and sometimes reckless behavior that can be part of bipolar disorder—or even stand alone as a manic episode. Bipolar disorder, often abbreviated as BD, involves swings between these high-energy manic states and deep lows of depression, making daily life unpredictable and challenging.

To dig deeper into this connection, the researchers analyzed a massive dataset of hospitalizations and ER visits in Canada from January 2008 through December 2022. They looked at three groups: individuals who sought urgent care specifically for hallucinogen-related issues, those hospitalized for unrelated reasons, and a broader slice of the general population. By tracking what happened in the three years after these initial visits, they compared the odds of later ER trips or admissions for mania, or receiving a bipolar disorder diagnosis. And here's where it gets controversial: The findings suggest that hallucinogens might not just be harmless fun or miracle cures—they could ignite serious mental health risks in vulnerable people.

Let's break down the numbers for clarity. The study examined records from 7,285 patients who had acute care due to hallucinogen use and compared them to 78,201 others who were hospitalized for different causes. What they found was striking: Those with hallucinogen-related ER or hospital visits were six times more likely to require treatment for mania within the next three years, and four times more likely to get diagnosed with bipolar disorder. For context, this heightened risk mirrors what's been observed with cannabis use, which researchers have previously linked to similar manic outcomes—think of it like comparing two potent substances that can disrupt the brain's delicate balance. Additionally, about two-thirds of the hallucinogen group had a history of prior substance use visits, and nearly half had previous mental health care encounters. This paints a picture of individuals who might already be navigating complex challenges, making it harder to pinpoint the drugs as the sole culprit.

But here's the part most people miss—and where opinions really start to diverge: The researchers emphasize that their data mostly reflects non-medical exposure, based on the timeframe studied. Plus, these results only apply to those who needed urgent healthcare after using hallucinogens; they don't capture the majority who experiment recreationally or therapeutically without landing in crisis. In other words, if you're using these substances under controlled medical supervision or in small, safe doses, you might dodge these risks altogether. However, the team suggests that any hallucinogen use leading to an ER visit or hospitalization could signal an elevated chance of later mania or BD development. And this is where it gets really provocative: Could it be that hallucinogens directly trigger these conditions, or is the association more about who uses them? The authors themselves note that the link might stem from hallucinogen users already being predisposed to mania or BD, rather than the drugs causing it outright. It's a debate that flips the script—maybe these substances are innocent bystanders, highlighting pre-existing vulnerabilities instead of creating new ones.

Lead author Daniel Myran sums it up bluntly: 'Our study showed a strong association between hallucinogen use that requires care in the emergency room or hospital and future risk of mania and bipolar disorder.' He goes on to add, 'There has been a large increase in interest in the use of hallucinogens, often paired with therapy, to treat some mental health disorders. The current study helps highlight that hallucinogen use outside of trial settings may have important risks for a subset of people who use them.' Coauthor Marco Solmi echoes this complexity, explaining, 'Our results fill an important gap around the complexity of therapeutic versus safety profile of hallucinogen use. Future projects will need to identify predictors of beneficial versus harmful outcomes at the individual level.'

To put this in perspective, consider examples like psilocybin-assisted therapy for PTSD, which has shown promise in clinical trials for reducing symptoms, or ketamine infusions used in hospitals for severe depression. Yet, if someone takes a high dose recreationally and ends up in a bad trip requiring medical intervention, it might set the stage for long-term issues. It's a balancing act: the potential for healing versus the risk of harm, especially for those with underlying mental health sensitivities.